Physician-patient gender concordance may not matter in interventional practice
(Michigan Medicine - University of Michigan) While some studies suggest female patients treated by female physicians have better outcomes, there does not appear to be a relationship between operator and patient gender and outcome in patients undergoing coronary angioplasty or stenting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 25, 2021 Category: International Medicine & Public Health Source Type: news
Stents or bypass surgery more effective for stable patients with high-risk cardiac anatomy
(University of Alberta Faculty of Medicine& Dentistry) A study by University of Alberta cardiologists at the Canadian VIGOUR Centre shows that a particular group of patients with stable ischemic heart disease have better outcomes with percutaneous coronary intervention (also called angioplasty with stent) or coronary artery bypass surgery and medication, versus conservative management with medication alone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 18, 2021 Category: International Medicine & Public Health Source Type: news
Primary PCI Use Down for Cancer Patients With STEMI
WEDNESDAY, Feb. 17, 2021 -- Patients with active cancer who have ST-elevation myocardial infarction (STEMI) receive primary percutaneous coronary intervention (pPCI) less often, but they have significantly lower rates of in-hospital all-cause... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 17, 2021 Category: Pharmaceuticals Source Type: news
Cancer patients not receiving life-saving heart attack treatment
(European Society of Cardiology) Emergency heart attack treatment is effective in patients with cancer, yet many do not receive it. That's the finding of a study published on World Cancer Day in European Heart Journal - Acute Cardiovascular Care, a journal of the European Society of Cardiology (ESC).1 This was the first study to compare the rates of primary percutaneous coronary intervention (PCI) in heart attack patients with and without cancer, and to examine the comparative effectiveness and safety of treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 3, 2021 Category: Cancer & Oncology Source Type: news
Symptom-to-Balloon Time Linked to Infarct Size in STEMI
THURSDAY, Jan. 14, 2021 -- For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI), symptom-to-balloon time (SBT), but not door-to-balloon time (DBT), is associated with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 14, 2021 Category: Pharmaceuticals Source Type: news
Physician-Level PCI Mortality Data May Be Misleading Physician-Level PCI Mortality Data May Be Misleading
Percutaneous coronary intervention mortality data do not adequately reflect the quality of care delivered by cardiologists who perform this procedure at multiple centers, researchers report.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 4, 2021 Category: Intensive Care Tags: Cardiology News Source Type: news
Clopidogrel Bests Ticagrelor for Elective PCI Clopidogrel Bests Ticagrelor for Elective PCI
Ticagrelor failed to unseat clopidogrel as the guideline-recommended P2Y12 inhibitor of choice in patients undergoing elective percutaneous coronary intervention for stable CAD in the randomized ALPHEUS trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 15, 2020 Category: Cardiology Tags: Cardiology News Source Type: news
Results from the TARGET FFR study reported at TCT Connect
(Cardiovascular Research Foundation) Results from the randomized controlled TARGET FFR trial show that while a physiology-guided percutaneous coronary intervention (PCI) optimization strategy did not achieve a significant increase in the proportion of patients with final FFR ?0.90, it reduced the proportion of patients with a residual FFR ?0.80 following PCI. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 16, 2020 Category: International Medicine & Public Health Source Type: news
Medtronic Resolute Onyx ™ Drug Eluting Stent (DES) First to Receive One-Month DAPT Labeling in the U.S. with Expanded Indication for High Bleeding Risk Patients
Medtronic plc (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual-antiplatelet therapy (DAPT) labeling with an expanded indication for high bleeding risk (HBR) patients implanted with the Resolute Onyx ™ DES. The Resolute Onyx DES is the first-and-only DES in the U.S. that has been proven safe and effective utilizing a one-month regimen of DAPT – the combination of aspirin and an anti-clotting medication – following a percutaneous coronary intervention (PCI) in patients at high bleeding risk . (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - October 1, 2020 Category: Cardiology Source Type: news
CYP2C19 Genotyping May Aid Antiplatelet Prescribing
WEDNESDAY, Sept. 9, 2020 -- Genotyping may provide some clinical benefit in prescribing antiplatelet therapies for patients undergoing percutaneous coronary intervention (PCI), according to a study published in the Aug. 25 issue of the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 9, 2020 Category: Pharmaceuticals Source Type: news
International registries show PCI rates increased in Japan, US
(American College of Cardiology) Japan and the US have seen an increase in percutaneous coronary intervention (PCI) procedures, which is driven primarily by a rise in elective PCIs in Japan compared to non-elective in the U.S., according to a study in the Journal of the American College of Cardiology. Since adoption of large-scale PCI trial results vary internationally, the study sought to analyze large national registries in both countries to illuminate international variation in PCI practice as a foundation for further quality improvement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2020 Category: International Medicine & Public Health Source Type: news
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction, Heart
Study (n=34,127) found decline by 43% in the number of PCI procedures for STEMI in April 2020 vs the average between 2017 and 2019, but the in-hospital mortality rate was not higher during the lockdown (3.5% vs 4.8% before the lockdown). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 3, 2020 Category: Consumer Health News Source Type: news
Genetic testing cut adverse events in heart patients
Personalized genetic testing led to a 34% decrease in the number of patients...Read more on AuntMinnie.comRelated Reading:
USPSTF advises against carotid artery stenosis screening
Abbott recalls 2 coronary angioplasty catheters
FDA offers guidance on angioplasty and specialty catheters
USPSTF opens review of carotid stenosis screening
Coronary CTA beats stress test for changing lifestyles (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 27, 2020 Category: Radiology Source Type: news
Largest pharmacogenetic clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet therapy
ROCHESTER, Minn. ? Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement? nonsurgical procedures to improve blood flow to the heart ? are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - August 24, 2020 Category: Hospital Management Source Type: news
Black patients have higher rates of death after PCI
(American College of Cardiology) Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major adverse outcomes, including death, compared to white patients, according to a study published today in JACC: Cardiovascular Interventions. The study underscores the high rates of cardiovascular disease and risk factors in minorities and continued need for further research on race-based outcomes after cardiovascular procedures, including PCI, to understand and alleviate these differences. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 6, 2020 Category: International Medicine & Public Health Source Type: news
